Netskope Announces Pricing of Initial Public Offering
PR Newswire
Today at 11:32pm UTC
Ascletis Presented Phase III Study Results of First-in-Class FASN Inhibitor Denifanstat (ASC40) for Acne Treatment in the Late Breaking News...
PR Newswire
Today at 11:30pm UTC
ChowChow Cloud Announces Pricing of Initial Public Offering
GlobeNewswire
Today at 11:14pm UTC
Nabors Energy Transition Corp. II Announces Extension of Deadline to Complete Business Combination
PR Newswire
Today at 11:13pm UTC
Streamex Corp., NASDAQ: STEX & Simplify Asset Management $10 billion USD AUM ETF Manager Announces Letter of Intent Pursuing a Strategic...
GlobeNewswire
Today at 11:01pm UTC
Rosen Law Firm Investigates Disney's Potential Violation of Children's Privacy Rights
PR Newswire
Today at 10:53pm UTC
Vermejo Unveils "The Season of Sabbatical": A Purpose-Driven Winter Experience in Nature
PR Newswire
Today at 10:48pm UTC
Moran, Allen & Associates Wins Permanent Protection Order Against Domestic Violence Abuser
PRUnderground
Today at 10:42pm UTC
MIDAS and OLEON join forces to advance sustainable immersion cooling for data centers
PR Newswire
Today at 10:37pm UTC
Charlie Kirk, ‘A Voice for the Voiceless,’ Leaves Legacy Inspiring Global Democracy, Says Zahid F Sarder Saddi
GlobeNewswire
Today at 10:35pm UTC
River Valley Community Bancorp Appoints Robert F. Sinclair, Director
GlobeNewswire
Today at 10:27pm UTC
/DISREGARD RELEASE: Bailess Law Firm/
PR Newswire
Today at 10:25pm UTC
Alabama's Premier Hispanic Heritage Festival Returns to Birmingham for 23rd Year
PR Newswire
Today at 10:19pm UTC
ECD Automotive Design Corrects CUSIP Number
GlobeNewswire
Today at 10:15pm UTC
RCI ALERT: Bragar Eagel & Squire, P.C. is Investigating RCI Hospitality Holdings, Inc. on Behalf of RCI Stockholders and Encourages...
GlobeNewswire
Today at 10:15pm UTC
Top Marketing Agency in Orlando Offers Comprehensive Digital Solutions
Press Services
Today at 10:10pm UTC
DOW INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Dow Inc. Investors with Substantial Losses Have Opportunity to...
PR Newswire
Today at 10:02pm UTC
Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and...
PR Newswire
Today at 10:01pm UTC
Do You Always Need Probate in California? When Carlsbad Families Can Avoid Court
Press Services
Today at 10:00pm UTC
Winterizing Your GMC: Essential Repair & Maintenance Tips in Layton, UT
Press Services
Today at 10:00pm UTC